Endeavor

Combination Therapy Before Surgery Shows Promise for Aggressive Skin Cancer

Moffitt-led study explores how pairing lenvatinib and pembrolizumab strengthens immune response against Merkel cell carcinoma

Experimental Injectable Therapy Offers Nonsurgical Treatment of Common Skin Cancer

Phase 2 study led by Moffitt researchers finds VP-315 triggers strong local and systemic immune response against basal cell carcinoma

TIL Therapy Research Expanded to Bladder Cancer

Almost half of patients enrolled in a Moffitt trial responded to the cellular immunotherapy

On Course for a Full Life

After beating oropharynx cancer, Eric Bilow shows there’s no challenge he won’t take on

Moffitt’s McKinley Outpatient Center Celebrates 10th Anniversary

Even a decade after its opening, the campus continues to evolve

Can Hybrid Immunotherapy Improve Solid Tumor Treatment?

Moffitt researchers test CAR-TIL cells combining tumor navigation and targeted attack

Honoring a Legacy of Compassion at Moffitt

The Patti K. Halula Legacy Award celebrates team members who lead with heart, humility and humanity

Flipping the Switch: New Moffitt Research Offers 2 Ways To Outsmart Drug Resistance in Lung Cancer

Two companion studies reveal new ways to prevent and defeat drug resistance in KRAS-driven lung cancer

Screening Is Key To Reduce Lung Cancer Deaths, Experts Say

 In Florida, only 16% of the people who should be getting screened for lung cancer are screened